AndroScience Corporation

AndroScience (ASC) focuses on innovating small molecules targeting high therapeutic and commercial value, including signaling and transcription factors, receptors, and intracellular signaling cascades. Leveraging expertise in natural product chemistry, ASC’s robust internal drug discovery and preclinical screening processes have advanced novel candidate drugs through early and mid-stage clinical trials for multiple clinical indications.